When it comes to your cleaning necessities, get ready to shell out some cash for less products.
Proctor & Gamble, the parent company of many of your go-to cleaning supplies like Cascade, Tide, and Swiffer, among others, is set to hike the prices on many of its goods. The company cites inflation and the cost to manufacture its products as the reason behind the increases.
On Thursday, the company reported year-over-year declines in sales, revenue and profits despite raising prices to offset losses. The dropoff was linked to a slip in consumer demand.
In concert with the price hikes, P&G is also set to scale back on its product sizes. Known as shrinkflation, consumers will pay the increased cost while simultaneously receiving less product than they had previously for the item.
Even as demand dwindles for the consumer-goods behemoth, P&G has no plans to lower price in the short-term. In Thursday's earnings call, Andre Schulten, chief financial officer at P&G, said consumers continue to make purchases because the items his company provides are necessities.
"Consumers don't stop washing their hands or doing their laundry," he noted.
Prices are set to increase even more in the coming months. P&G also boosted its 2023 sales outlook to a range between 4 and 5 percent growth.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
